Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China flag China · Delayed Price · Currency is CNY
141.18
-0.01 (-0.01%)
May 8, 2026, 3:00 PM CST

SHA:600436 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,9571,2561,4881,1592,4967,097
Short-Term Investments
-1,2923,5209,0146,202-
Trading Asset Securities
-----8.8
Cash & Short-Term Investments
1,9572,5485,00810,1738,6987,106
Cash Growth
40.36%-49.12%-50.78%16.95%22.42%37.48%
Accounts Receivable
942.87830.91894.431,021859.49673.3
Other Receivables
115.5367.963.9565.15107.94134.95
Receivables
1,058898.81958.381,086967.43808.25
Inventory
6,2786,6794,9673,3792,6282,438
Prepaid Expenses
-97.2812.8214.054.5520.68
Other Current Assets
2,135445.83382.92447.9406.61261.36
Total Current Assets
11,42810,66911,32915,10012,70510,633
Property, Plant & Equipment
2,0471,9371,508614.62465.62400.14
Long-Term Investments
1,3041,364870.45631.98673.7799.87
Other Intangible Assets
263.85267.49273.1291.09319.37220.96
Long-Term Deferred Tax Assets
118.46115.43155.5187.31167.26166.98
Long-Term Deferred Charges
28.6930.5434.0529.9937.6544.19
Other Long-Term Assets
3,1943,1773,370225.4235.41255.59
Total Assets
18,38517,56017,54017,08014,60412,521
Accounts Payable
567.29547.81480.01667.92464.9386.99
Accrued Expenses
140.21275.91485.41685.98345.39342.14
Short-Term Debt
841.4838.13892.79989.93970.96775.79
Current Portion of Long-Term Debt
44.337.676.991.87--
Current Portion of Leases
-32.6235.8131.8629.2122.75
Current Income Taxes Payable
206.285.0659.07142.6572.93108.96
Current Unearned Revenue
232.18269.18270.81237.1468.57326.56
Other Current Liabilities
243.98148.2142.92125.8158.22173.9
Total Current Liabilities
2,2762,1252,3742,8832,5102,137
Long-Term Debt
52.2856.0858.1535.44--
Long-Term Leases
130.01127.66154.58107.29108.886.67
Long-Term Unearned Revenue
25.8626.2626.6817.6717.0120.24
Pension & Post-Retirement Benefits
52.6853.1753.2835.0434.2932.23
Long-Term Deferred Tax Liabilities
61.5152.980.3330.0261.0974.52
Other Long-Term Liabilities
30.3731.2334.151.3548.5432.88
Total Liabilities
2,6282,4722,7013,1602,7802,384
Common Stock
603.32603.32603.32603.32603.32603.32
Additional Paid-In Capital
1,0951,0951,0951,0951,0941,086
Retained Earnings
13,45312,70912,49711,6029,5597,816
Comprehensive Income & Other
61.71132.1876.9276.674.41200.05
Total Common Equity
15,21314,53914,27213,37611,3309,705
Minority Interest
543.73548.58567.01544.17493.97432.07
Shareholders' Equity
15,75615,08814,83913,92011,82410,138
Total Liabilities & Equity
18,38517,56017,54017,08014,60412,521
Total Debt
1,0681,0621,1481,1661,109885.21
Net Cash (Debt)
888.81,4863,8599,0077,5896,220
Net Cash Growth
186.81%-61.50%-57.15%18.67%22.01%39.78%
Net Cash Per Share
1.472.466.3914.9412.5910.31
Filing Date Shares Outstanding
603.32603.32603.32603.32603.32603.32
Total Common Shares Outstanding
603.32603.32603.32603.32603.32603.32
Working Capital
9,1538,5448,95512,21710,1958,496
Book Value Per Share
25.2124.1023.6622.1718.7816.09
Tangible Book Value
14,94914,27213,99913,08511,0119,484
Tangible Book Value Per Share
24.7823.6623.2021.6918.2515.72
Buildings
-624.021,095400.13331.45332.55
Machinery
-408.37368.02345.33324.4300.25
Construction In Progress
-1,248314.85157.1960.7814.94
Source: S&P Global Market Intelligence. Standard template. Financial Sources.